9/2/2009

The FDA's draft guidelines on stating risk information in promotional materials mainly focus on drugs and fail to consider factors specific to medical devices, AdvaMed said. In its comments to the FDA, the trade group advised the agency to create a separate guidance for device ads.

Related Summaries